PLEXITOME™
Recurrent Corneal Erosion (RCE) and large corneal abrasions
CommercialActive
Key Facts
Indication
Recurrent Corneal Erosion (RCE) and large corneal abrasions
Phase
Commercial
Status
Active
Company
About VEO Ophthalmics
VEO Ophthalmics is a private, commercial-stage medical device company specializing in ophthalmic surgical tools. The company achieved a significant regulatory milestone with the FDA's first Breakthrough Device designation and approval for its CUSTOM FLEX® Artificial Iris, addressing iris defects. With a second commercial product, PLEXITOME™, for corneal conditions, VEO operates in a high-value niche, leveraging direct surgeon feedback to drive innovation and commercial execution in the ophthalmology market.
View full company profile